Shares of Coretec Group (OTCMKTS:CRTG) continues to trade in a narrow range over the past weeks.
On Wednesday, CRTG stock ended flat at $0.0800 with more than 541k shares, compared to its average volume of 285K shares. The stock has moved within a range of $ 0.0730 – 0.0800 after opening the trade at $0.0750.
Developers of engineered silicon and 3D volumetric displays, The Coretec Group (OTCMKTS:CRTG) announced the promotion of Dr.RamezElgammal to Chief Technology Officer and Dr. Michelle Tokarz to Vice President of Partnerships & Innovation.
The company is moving forward in developing a number of technologies across sectors including quantum dots, batteries as well as semiconductors. Furthermore, it is expanding and promoting the team as well.
While Tokarz is a blend of businessperson and scientist, having developed the acumen in the pharmaceutical industry, Dr.Ramez has a broad background in science, engineering, and entrepreneurship. Tokarz held research chemistry and production roles with Eli Lilly and Merck while Ramez is a Senior Research Associate at the University of Tennessee managing a broad spectrum of projects in energy storage.
Matthew Kappers, the CEO, said that Ramez and Michelle are key to the growth of the group, and the joint knowledge, industry connections as well as expertise is unmatchable. Kappers added that the two also have an entrepreneurial spirit that can drive the team.
The Coretec Group, Inc also announced details for the 10 AM (EST) November 17, 2021 shareholder call, during which the firm will be hosting a Q&A conference call for discussing future initiatives as well as accomplishments.
Users are welcome to send emails to IR@thecoretecgroup.com for any queries and Matthew Kappers, Chief Executive Officer, Matthew Hoffman, Chief Financial Officer as well as Simon Calton, Director, will be responding to the questions.
CRTG stock is trading below the 50-Day and 200-Day Moving averages of $0.0858 and $0.1277 respectively. Moreover, the stock is trading above the 20-Day moving average of $0.0773. The stock is down 40% over the past quarter.